ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0102

Impact of Racial Implicit Bias on Juvenile Idiopathic Arthritis Patients’ Treatment Recommendations

Alisha Akinsete1, Illir Agalliu2, Dawn Wahezi1, Ellen Silvers2, Onjona Hossain2, Irene Blanco2, Tamar Rubinstein3 and Cristina Gonzalez2, 1Children's Hospital at Montefiore, Bronx, NY, 2Albert Einstein College of Medicine, Bronx, NY, 3Albert Einstein College of Medicine, White Plains, NY

Meeting: ACR Convergence 2022

Keywords: Disparities, Health Services Research, Juvenile idiopathic arthritis, race/ethnicity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: Healthcare Disparities in Rheumatology Poster

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: There are racial and ethnic disparities in juvenile idiopathic arthritis (JIA). Implicit bias can contribute to these health disparities through provider communication and medical decision-making. For example, studies have shown that racial implicit bias can affect pain management recommendations in pediatric patients. Early aggressive treatment with biologic treatment has been shown to be more effective than conventional DMARDs. In this study we described the implicit racial and racial/medical adherence biases of the international pediatric rheumatology community and investigated their associations with treatment recommendations and perception of compliance.

Methods: Our study recruited an international cohort of faculty, fellows, physician assistants and nurse practitioners practicing in pediatric rheumatology from Nov 2021 through Feb 2022. Demographic data was collected via an online survey, after which participants participated in two online timed modules, designed to determine the “inappropriate vs appropriate vs aggressive” treatment for the JIA patients based on the data provided. Patients differed by race (White vs Black). Participants were then asked to assess how adherent the patient would likely be with treatment. Following the vignettes, participants completed the adult race Implicit Assessment Test (IAT) and the adult race and medical compliance; an IATD-score was given. A positive IAT score indicates a pro-White bias and a negative a pro-Black bias, 0 is no bias. The IAT scores range from -2 to +2. The student T-test and one-way ANOVA were used to compare IAT scores between groups. Logistic regression models were used to examine the associations of the following variables(provider age, sex, race, job title, years of experience) to the participant IAT scores with regards to the outcome variable of interest: either appropriate or aggressive treatment within each vignette (white vs black).

Results: A total of 165 providers completed the survey, modules and IATs. The majority were women (64%), White (79%) and faculty (76%). Overall, providers showed a slight pro-White bias (mean IAT D score= 0.26, SD=0.51) and slight pro-White bias with medical compliance stereotype (mean IAT D score= 0.16, SD=0.43). There were no differences in appropriate or aggressive treatment recommendations associated with IAT scores for White or Black vignettes, although the results were based on small sample size. Interestingly, there was an inverse association between the IAT score where in the Black vignette the providers we less likely to give aggressive therapy as the pro-White bias increased (OR=0.54, 95% CI 0.20-1.46, p=0.23 per unit increase in IAT) whereas in the White vignette providers were more likely to give aggressive treatment as the pro-White bias (OR= 4.07 95% CI 0.75-22.24 p=0.11). Nonetheless, findings were not statistically significant.

Conclusion: : In this feasibility study, Implicit Bias was not associated with treatment recommendation or perceived compliance of JIA patients. Further larger studies are needed to better evaluate implicit bias’s impact on provider communication.

Supporting image 1

Provider Characteristics Assigned to Clinical Vignettes

Supporting image 2

Providers Who Completed Implicit Association Tests


Disclosures: A. Akinsete, None; I. Agalliu, None; D. Wahezi, None; E. Silvers, None; O. Hossain, None; I. Blanco, Novartis; T. Rubinstein, None; C. Gonzalez, None.

To cite this abstract in AMA style:

Akinsete A, Agalliu I, Wahezi D, Silvers E, Hossain O, Blanco I, Rubinstein T, Gonzalez C. Impact of Racial Implicit Bias on Juvenile Idiopathic Arthritis Patients’ Treatment Recommendations [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/impact-of-racial-implicit-bias-on-juvenile-idiopathic-arthritis-patients-treatment-recommendations/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/impact-of-racial-implicit-bias-on-juvenile-idiopathic-arthritis-patients-treatment-recommendations/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology